MedPath

Study of Anatomo-functional Correlation of the Upper Airways

Not Applicable
Active, not recruiting
Conditions
Sleep Apnea Syndromes
Interventions
Other: Measurement of pharyngeal critical airway closing pressure
Other: Acoustic pharyngometry
Other: Upper airway ultrasound
Registration Number
NCT05774522
Lead Sponsor
Assistance Publique - H么pitaux de Paris
Brief Summary

Sleep apnea-hypopnea syndrome (SAHS) is a disorder of nocturnal ventilation due to the occurrence abnormally frequent pauses in breathing. It is a public health problem that currently affects 13 % of men and 6% of women between 30 and 70 years old. Sleep apneas are conventionally divided into obstructive and central apneas, depending on the persistence or no respiratory movements and the existence or not pharyngeal collapse during apnea. There are upper airway characterization studies (VAS) in patients with syndrome sleep apnea/hypopnea (OSAS). These physiological characterization studies (measurement of critical closing pressure (Pcrit) of the VAS) and anatomical (transcutaneous ultrasound of the muscles of the floor of the mouth, the base of the tongue, or by a acoustic pharyngometry of the VAS) are interested separately to different parameters without searching correlation with the severity of sleep apnea nor their potential as a screening tool for OSAS in patients at risk. The investigators hypothesize that a strong correlation and constant exists between the physiological collapsibility of VAS, the anatomical measurements of the VAS and the degree of severity of OSAS. Thus, the aim of this descriptive study is to characterization as complete as possible of the VAS of apneic patients in a homogeneous population and a better understanding of the pathophysiological obstructive events in patients without factor obvious risk.

Detailed Description

Obstructive sleep apnea-hypopnea syndrome (OSAS) is a nocturnal respiratory disorder caused by a succession of respiratory pauses. The prevalence of OSAHS has increased over the past two decades partly due to the fact that it is more often diagnosed but also due to the progression of obesity. It now affects 13% of men and 6% of women between the ages of 30 and 70. Sleep apneas are conventionally divided into obstructive and central apneas, depending on whether or not respiratory movements persist and whether or not there is pharyngeal collapse during the apnea. Continuous positive airway pressure (CPAP) ventilation via a nasal or naso-buccal mask is the reference treatment. The effectiveness of CPAP is directly linked to its observance. A well conducted treatment allows a significant improvement of symptoms related to OSAHS and effectively reduces daytime sleepiness. In the longer term, it would provide protection against cardiovascular events.

The physiopathology of obstructive apnea has been the subject of in-depth studies; the most recent data show that it is a multifactorial disease. Among the factors implicated, the investigators can cite pharyngeal anomalies (anatomy and collapsibility), a significant ventilatory response ("high loop gain") in response to variations in partial pressure of CO2 (pCO2), a weak pharyngeal muscle response during sleep and a high wakefulness threshold. Each of them can be evaluated by different methods: anatomy by a standardized clinical examination and imaging techniques, some of which have not yet been the subject of anatomo-functional correlation studies (such as the ultrasound or acoustic pharyngometry); collapsibility by measuring the critical closure pressure (Pcrit) (pressure applied at which closure of the airways is observed); the ventilatory response by analysis of the SpO2 and PCO2 signals in the exhaled air (PETCO2) in calm ventilation and ventilatory slope of response to hypercapnia; pharyngeal electromyogram and polysomnographic analysis.

The respective importance of these factors seems to vary greatly from one individual to another, but their characterization would make it possible to propose new avenues of treatment targeting the "loop gain", the pharyngeal muscle tone or the arousal threshold, and d adapt these targets to each patient for a personalized treatment.

The investigators hypothesize that a correlation exists between the physiological collapsibility of the VAS, the anatomical measurements of the VAS and the degree of severity of OSAHS. The objectives of our study are to identify clinical and physiological phenotypes of apneic patients, with the prospect of screening tools, a better distribution of targeted diagnostic and therapeutic resources.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Suspicion of sleep apnea syndromeMeasurement of pharyngeal critical airway closing pressureAll patients, consulting Bichat sleep center for suspected sleep apnea syndrome
Suspicion of sleep apnea syndromeUpper airway ultrasoundAll patients, consulting Bichat sleep center for suspected sleep apnea syndrome
Suspicion of sleep apnea syndromeAcoustic pharyngometryAll patients, consulting Bichat sleep center for suspected sleep apnea syndrome
Primary Outcome Measures
NameTimeMethod
measure of the values of critical closing pressure of the upper airwayduring procedure
The measurements in cm of tissus thickness of the upper airways by ultrasoundduring procedure
measure the cross-sectional area of the upper airway by a acoustic pharyngometryduring procedure
Secondary Outcome Measures
NameTimeMethod
measure of pharyngeal volume by ultrasoundduring procedure
predictive value of ultrasound measurements (Sp, Se)during procedure
predictive value (Sp, Se) of acoustic pharyngometry measurementsduring procedure
measure of pharyngeal collapsibility by ultrasoundduring procedure
measure of apnea hypopnea index by polysomnographyduring procedure

Trial Locations

Locations (1)

H么pital Bichat-Claude Bernard

馃嚝馃嚪

Paris, France

漏 Copyright 2025. All Rights Reserved by MedPath